Brandon Tom

As President & Chief Executive Officer of Orsini Specialty Pharmacy, Brandon Tom is responsible for leading the organization’s strategy to serve as a comprehensive and innovative commercialization partner to biopharmaceutical manufacturers of rare disease and gene therapy medications, as well as build a strong, patient-centered, team and culture. A seasoned leader, Brandon brings over 15 years of specialty and biopharma services experience. Prior to joining Orsini, Brandon was Vice President and General Manager of Biologics by McKesson, the leading independent oncology-focused specialty pharmacy, where he had responsibility for all aspects of the business, including the responsibility of over 75 limited distribution and exclusive therapies. Prior to Biologics, Brandon advanced quickly through multiple leadership positions within McKesson’s specialty businesses, including the group purchasing organization (GPO), The US Oncology Network, specialty distribution and corporate strategy. Before McKesson, Brandon held various roles at a national health plan. He is a licensed pharmacist in California, earned a Doctorate of Pharmacy from the University of the Pacific, and a bachelor of science from UCLA.